PFE — PFIZER INC
Health Care · Drug Manufacturers
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying PFE?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their PFE position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime). 0 congressional purchases, 2 sales disclosed in the last 6 months.
- +1 tracked investor added or increased positions last quarter (Michael Burry)
- +5 tracked investors reported holding PFE at their latest filing
- +Macro Health is 52/100 in a Squeeze regime — historically acceptable for Health Caresource
- −Congressional disclosures lean toward selling (2 sales vs 0 purchases, 6 months)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About PFIZER INC (PFE)
PFIZER INC (PFE) appears in the most recent 13F filings of 5 tracked institutional investors. PFIZER INC is classified in the Health Care sector (Drug Manufacturers industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $855M. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in PFE
How many top investors track PFE
A small number of top investors own this.
PFE Ownership Composition
How PFIZER INC is held across tracked investor types, based on reported 13F positions.
- Other73.1%
- Hedge Funds26.9%
Tracked investors reporting PFE
- Ken GriffinMar 31, 2026Citadel AdvisorsShares28.4MValue$797.6M% Portfolio0.13%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares7.2MValue$203M% Portfolio0.26%
- Michael BurrySep 30, 2025Scion Asset ManagementShares6MValue$152.9M% Portfolio11.07%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares5.3MValue$148.2M% Portfolio0.06%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares729.5KValue$20.5M% Portfolio0.04%
Recent activity
- $152.9MNov 3, 2025
Frequently asked questions
- How many institutional investors hold PFE?
- 5 tracked institutional investors disclosed a position in PFE (PFIZER INC) in their most recent 13F filing.
- Who is the largest institutional holder of PFE?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in PFE, valued at $855M.
- Did institutional ownership of PFE increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited PFE.
- What sector is PFE in?
- PFIZER INC is classified in the Health Care GICS sector, Drug Manufacturers industry.
- Where does this PFE ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.